VJHemOnc is committed to improving our service to you

EHA 2019 | NHS: drug funding and approval

VJHemOnc is committed to improving our service to you

Paresh Vyas

Paresh Vyas, MRCP, FRCP, FRCPath, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, tells us about the drug funding and approval system used by NHS England. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter